Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-09-12FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA granted supplemental approval for the fixed-dose combination of amlodipine besylate and atorvastatin calcium by Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2018-09-07Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of YHP1701 [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of YHP1701 for hypertension and hyperlipidemia has been completed.
-
CLINICAL_TRIALS trial_result · 2018-09-06Clinical Trial Update: Adrenal Artery Ablation for Uncontrolled Hypertension [Phase 3]
Phase 3 clinical trial update for adrenal artery ablation as a treatment for uncontrolled hypertension.
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: Azilsartan in Chinese Patients With Mild and Moderate Hypertension [Phase 3]
Phase 3 clinical trial update for azilsartan in Chinese patients with mild to moderate hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Adrenal Artery Ablation for Primary Aldosteronism [Phase 3]
A Phase 3 clinical trial update on adrenal artery ablation for primary aldosteronism and hypertension is ongoing, with status currently unkn…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Bioequivalence Study Between GSK3542503 Hydrochlorothiazide + Amiloride Hydrochloride 50 mg: 5 mg Tablets and Reference Product in Healthy Adult Participants Under Fasting Conditions [Phase 1]
Phase 1 bioequivalence study of GSK3542503 hydrochlorothiazide + amiloride hydrochloride 50 mg 5 mg tablets vs reference product in healthy …
-
FDA approval · 2018-08-30FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approves Upsher-Smith's generic diltiazem hydrochloride through an original ANDA (ANDA205231) for use as a calcium channel blocker.
-
FDA approval · 2018-08-28FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
The FDA approved a supplemental application for Losartan Potassium Tablets, 25 mg from Jubilant Cadista Pharmaceuticals, authorizing this ge…
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia [Phase 3]
Phase 3 trial updating safety and efficacy evaluation of CJ-30061 in patients with hypertension and hyperlipidemia.
-
CLINICAL_TRIALS trial_result · 2018-08-20Clinical Trial Update: Efficacy and Safety of Nebivolol Versus Metoprolol in Hypertensive Subject Taking Amlodipine [Phase 4]
Phase 4 trial comparing nebivolol to metoprolol for efficacy and safety in hypertensive patients taking amlodipine has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Losartan/Amlodipine on Hemodynamics Parameters and Arterial Stiffness in Arterial Hypertension [Phase 4]
Phase 4 trial update on the hemodynamics and arterial stiffness effects of losartan/amlodipine in hypertension.
-
FDA approval · 2018-08-17FDA Approved: SODIUM NITROPRUSSIDE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original ANDA for Sodium nitroprusside from Somerset Therapeutics, LLC, authorizing a generic IV vasodilator for use in hyp…
-
FDA approval · 2018-08-16FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Sandoz's generic benazepril hydrochloride and hydrochlorothiazide combination, validating its us…
-
FDA approval · 2018-08-08FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for benazepril hydrochloride and hydrochlorothiazide, submitted by Padagis US LLC.
-
FDA approval · 2018-08-08FDA Approved: LASIX — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for LASIX (furosemide) from Validus Pharmaceuticals LLC.
-
FDA approval · 2018-08-01FDA Approved: ENALAPRIL MALEATE — Supplemental Application (OCEANSIDE PHARMACEUTICALS)
FDA approved a supplemental application for enalapril maleate from Oceanside Pharmaceuticals, indicating an updated/expanded labeling for th…
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: 24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension [Phase 3]
A Phase 3 study evaluating 24-week efficacy and safety of empagliflozin in Black/African American patients with Type 2 diabetes mellitus and…
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Blood Pressure (BP) Visit Intensification Study [NA]
A completed clinical trial evaluating a visit intensification strategy for blood pressure management in hypertension.
-
FDA approval · 2018-07-30FDA Approved: NITROGLYCERIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Nitroglycerin submitted by Prasco Laboratories, signaling an approval-related action affecting t…
-
FDA approval · 2018-07-30FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for benazepril hydrochloride (generic) filed by Amneal Pharmaceuticals of New York LLC. This action …
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Integrated Hypertension and HIV Care Cascades in Uganda
A Ugandan clinical trial evaluating integrated hypertension and HIV care cascades has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: St. Vincent's Screening To Prevent Heart Failure Study [NA]
A completed clinical trial evaluating screening strategies to prevent heart failure in patients with left ventricular dysfunction and relate…
-
CLINICAL_TRIALS research · 2018-07-27Clinical Trial Update: Bedtime Potassium Losartan on CKD With Nocturnal Hypertension Patients With Nondipping Blood Pressure Pattern [NA]
A clinical trial update on bedtime dosing of losartan in patients with chronic kidney disease and nocturnal hypertension with nondipping blo…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Candesartan Cilexetil/Amlodipine Besilate Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"
ClinicalTrials.gov update shows results of the long-term safety and use surveillance for the candesartan cilexetil/amlodipine besilate combi…
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: Exploring the Effect of Combined Chinese and Western Treatment on Home Medical Care [NA]
This entry reports an update on a clinical trial evaluating the combined Chinese and Western treatment approach for hypertension in home med…